Evidence map›Paper›PMID 24748601›Full record

ReviewAmerican journal of physiology. Lung cellular and molecular physiology2014

Mitochondria in lung biology and pathology: more than just a powerhouse.

Paul T Schumacker, Mark N Gillespie, Kiichi Nakahira, Augustine M K Choi, Elliott D Crouser, Claude A Piantadosi, Jahar Bhattacharya

Registry-linked trialAbstract readReview
In one paragraph

Review in American journal of physiology. Lung cellular and molecular physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04445285 (Double Blind Randomized Phase 2 Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure), which is not on this map. Cited by 129 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
129citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04445285 phase2recruitingnot on this mapstarted 2020, after this paper: background citation

Double Blind Randomized Phase 2 Placebo Controlled Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure

TypeinterventionalSponsorJon SimmonsRan2020 to 2022Enrolled44ConditionsCovid19ArmsPulmozyme/ Recombinant human deoxyribonuclease (rh-DNase), 0.9%sodium chloride
3 · Its place in the literature

Who cites it

129 citing papers in PubMed, 1 synthesis or guideline pooled it, 197 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. GDF11-secreting cell transplant efficiently ameliorates age-related pulmonary fibrosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2025
    Article
  12. Pneumococcal HbioRxiv : the preprint server for biology · 2025
    Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

69 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Paul T SchumackerNorthwestern University Feinberg School of Medicine, Department of Pediatrics, Chicago, Illinois;
Mark N GillespieUniversity of South Alabama College of Medicine, Department of Pharmacology, Mobile, Alabama; mgillesp@southalabama.edu.
Kiichi NakahiraWeill Cornell Medical College, Department of Medicine, New York, New York;
Augustine M K ChoiWeill Cornell Medical College, Department of Medicine, New York, New York;
Elliott D CrouserThe Ohio State University College of Medicine, Department of Internal Medicine, Columbus, Ohio;
Claude A PiantadosiDuke University School of Medicine, Department of Medicine, Durham, North Carolina, and.
Jahar BhattacharyaColumbia University Medical Center, Department of Physiology and Cellular Biophysics, New York, New York.
Cornell University · USColumbia University Irving Medical Center · USDuke University · USNorthwestern University · USThe Ohio State University · USUniversity of South Alabama · US

Funding

Respiratory Computational Discovery CoreP01HL114501 · NHLBI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHOI, MARY E · 2013 to 2025
$24.9M
Mesenchymal Stromal Cell Conditioning by Carbon MonoxideP01HL108801 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI CHOI, AUGUSTINE M · 2011 to 2015
$13.8M
The Role of HEME Oxygenase in Hyperoxic Lung InjuryR01HL055330 · NHLBI · YALE UNIVERSITY · PI CHOI, AUGUSTINE M, CHOI, MARY E · 1998 to 2021
$6.6M
DNA LESIONS AND GENE EXPRESSION IN HYPOXIC LUNG DISEASER01HL058234 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI GILLESPIE, MARK N · 1998 to 2018
$5.2M
Respiratory and Metabolic Adaptation to HypoxiaR01HL035440 · NHLBI · UNIVERSITY OF CHICAGO · PI SCHUMACKER, PAUL T · 1986 to 2018
$5.0M
MtDNA repair: An isolated pharmacologic target in acute lung injuryR01HL113614 · NHLBI · UNIVERSITY OF SOUTH ALABAMA · PI GILLESPIE, MARK N · 2012 to 2021
$3.5M
Metabolic Regulation of Pulmonary Vascular RemodelingR01HL122062 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHUMACKER, PAUL T · 2014 to 2017
$2.0M
Redox Regulation of Lung Mitochondrial Biogenesis in Sepsis/PneumoniaR01AI095424 · NIAID · DUKE UNIVERSITY · PI PIANTADOSI, CLAUDE A · 2012 to 2016
$1.9M
Dendritic Cell Activation by Mitochondrial Transcription Factor AR21AI083912 · NIAID · OHIO STATE UNIVERSITY · PI CROUSER, ELLIOTT D · 2009 to 2010
$413k
Induction of Inflammation by Mitochondrial ProteinsR03AI062740 · NIAID · OHIO STATE UNIVERSITY · PI CROUSER, ELLIOTT D · 2005 to 2006
$148k
NHLBI NIH HHS P01 HL108801NHLBI NIH HHS P01 HL114501NHLBI NIH HHS R01 HL055330NHLBI NIH HHS R01 HL058234NHLBI NIH HHS R0 1 HL113614NHLBI NIH HHS R01 HL113614NHLBI NIH HHS R01 HL122062NHLBI NIH HHS R01 HL35440NIAID NIH HHS R01 AI083912NIAID NIH HHS R01 AI095424NIAID NIH HHS R01 AI62740
6 · The paper itself

Abstract

An explosion of new information about mitochondria reveals that their importance extends well beyond their time-honored function as the "powerhouse of the cell." In this Perspectives article, we summarize new evidence showing that mitochondria are at the center of a reactive oxygen species (ROS)-dependent pathway governing the response to hypoxia and to mitochondrial quality control. The potential role of the mitochondrial genome as a sentinel molecule governing cytotoxic responses of lung cells to ROS stress also is highlighted. Additional attention is devoted to the fate of damaged mitochondrial DNA relative to its involvement as a damage-associated molecular pattern driving adverse lung and systemic cell responses in severe illness or trauma. Finally, emerging strategies for replenishing normal populations of mitochondria after damage, either through promotion of mitochondrial biogenesis or via mitochondrial transfer, are discussed.

Indexed as

AnimalsBiomarkersDNA DamageDNA, MitochondrialHumansLungMitochondriaOxidative StressOxygenReactive Oxygen SpeciesRespiratory Distress SyndromeBiomarkersDNA, MitochondrialOxygenReactive Oxygen Specieshypoxialung injurymitochondrial biogenesismitochondrial transfermtDNA

Identifiers

PMID24748601
PMCPMC4042189
OpenAlexW1993321422

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.